Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > FDA in <2weeks?

<< Previous

Bullboard Posts

Next >>

Post by Kd5513on May 24, 2023 9:11am

203 Views

Post# 35461583

FDA in <2weeks?

We should have FDA response in less than 2 weeks if my math is correct.

It would be nice if leading up to this there was announcement of 2 board members have resigned and possible replacement with one high octane individual from US to back fill both. I'm a little irritated at this point it hasnt happened. How they could think they deserve a seat with the vote that just took place is mind boggling.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?